Last updated: Dec 17, 2024, 12:00 AM

Merrimack Pharmaceuticals Inc Exchange (NASDAQ, USD)

MACK

-
0.00 (0.00%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
18.02%
3 year return (CAGR)
35.00%
5 year return (CAGR)
26.66%
10 year return (CAGR)
-11.71%
Stock Analysis

Objective Corporation Stock Analysis – State Within State

Read More
Marketcap
223.75M
Price/Sales
-
Ent value
12.26M
Price/Book
1.01
Div yield
-
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-51.37%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

No data
Stock price data
Open15.15
Daily high15.16
Daily low15.13
Daily Volume1.26M
1y analyst estimate4.00
Beta1.42
EPS (TTM)-1.70
Dividend per share-
Ex-div date13 Dec 2019
Next earnings date-

Ready to capitalize on Merrimack Pharmaceuticals Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
MACKS&P500
Current price drop from All-time high-85.93%-0.06%
Highest price drop-98.48%-56.47%
Date of highest drop20 Mar 20209 Mar 2009
Avg drop from high-71.19%-10.68%
Avg time to new high113 days12 days
Max time to new high2284 days1805 days
News
No items found